Brown R H, Herold C J, Hirshman C A, Zerhouni E A, Mitzner W
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205.
J Appl Physiol (1985). 1993 Jun;74(6):2615-20. doi: 10.1152/jappl.1993.74.6.2615.
We directly measured the range of individual airway responses to aerosol and intravenous administration of histamine by using high-resolution computed tomography and then compared the heterogeneity in constriction responses between these two routes. Seven dogs were used for a total of eleven studies. Six of the seven dogs received intravenous histamine (100-300 micrograms/min) and five of the seven dogs received aerosolized histamine (0.01-3.0 mg/ml for 5 breaths). Data were analyzed using linear regression models calculating residual mean square values for each route of histamine as a measure of variability in the change in airway size. The residual mean square values for the absolute airway size after the aerosol and intravenous histamine challenges were 17.73 and 15.42, respectively, which were not significantly different [F(331,166) = 1.15, P = 0.32]. Also, there were no significant differences when we compared the log or the percent change in airway area for the two routes of administration. We conclude that the route of histamine administration does not significantly affect the heterogeneity of airway response, suggesting that the heterogeneity observed after the histamine challenge is predominantly controlled by local mechanisms in the airways.
我们通过使用高分辨率计算机断层扫描直接测量了个体气道对组胺气雾剂和静脉注射的反应范围,然后比较了这两种给药途径之间收缩反应的异质性。七只狗共进行了十一项研究。七只狗中的六只接受了静脉注射组胺(100 - 300微克/分钟),七只狗中的五只接受了组胺气雾剂(0.01 - 3.0毫克/毫升,持续5次呼吸)。使用线性回归模型分析数据,计算每种组胺给药途径的剩余均方值,作为气道大小变化变异性的一种度量。气雾剂和静脉注射组胺激发后绝对气道大小的剩余均方值分别为17.73和15.42,差异无统计学意义[F(331,166) = 1.15,P = 0.32]。此外,当我们比较两种给药途径气道面积的对数或百分比变化时,也没有显著差异。我们得出结论,组胺给药途径对气道反应的异质性没有显著影响,这表明组胺激发后观察到的异质性主要由气道中的局部机制控制。